Don't be left out - Register now to ensure your spot in the discussions these leaders will be guiding in two weeks.
1 Day of High-Quality Virtual Sessions
The digital transformation of the biopharma industry is in full swing. INVEST PharmaTech will bring together technology disruptors, Big Pharma and biotech leaders, investors and entrepreneurs to discuss how to adopt digital strategies to transform every aspect of the pharma industry.
Chief Data Science Officer, Global Head, Strategy and Operations, Janssen Pharmaceutical
Najat Khan, PhD, is the Chief Data Science Officer and the Global Head of Strategy & Operations for Janssen Research & Development. Dr Khan co-chairs the Johnson & Johnson Data Science Council and is a member of Janssen's Development and Investment Committees.
ADDITIONAL SPEAKERS
Lana Y. Ghanem Managing Director, Hikma Venturess
Jodi Akin CEO, Hawthorne Effect
Sharon Hanlon, MSN Head of Clinical Trial Engagement & Enrollment, Bristol Myers Squibb
Jessica Federer Partner, Boston Millennia Partners
No comments